Children’s National Health System:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Children’s National Health System - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10285
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Children’s National Health System (CNHS) formerly Children’s National Medical Center, is a health care institution which offers pediatric care services. The institution offers pediatric emergency, trauma, neonatal acre, neurosurgery, endocrinology, metabolic diseases and respiratory disorders, ear, nose and throat disorders services. It offers services in the area of cardiology, oncology, neurology, cancer, dermatology, immunology, intensive care, radiology, kidney diseases, and others. CNHS provides educational opportunities for internal and external physicians, nurses, and allied health professionals through internships, residency, fellowships, graduate medical education, and continuing medical education. The institution offers services through its research centers in District of Columbia, Maryland, and Virginia. CNHS is headquartered in Washington, D.C., the US.

Children’s National Health System – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Children’s National Health System, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Children’s National Health System, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Children’s National Health System, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Children’s National Health System, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Children’s National Health System, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Children’s National Health System, Medical Equipment, Deal Details 10
Partnerships 10
Regeneron Genetics Center Enters into Research Agreement with Children’s National Health System 10
OZ Systems Enters Into Co-Development Agreement With Children’s National Health System 11
Children’s National Health System Forms Joint Venture with Cerner 12
Summit Enters Into Co-Development Agreement With Children’s National Medical Center 13
Children’s National Health System – Key Competitors 14
Children’s National Health System – Key Employees 15
Children’s National Health System – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Feb 08, 2018: Al Jalila Children’s and Children’s National sign international health information technology agreement 18
Government and Public Interest 19
Oct 15, 2018: Blood test ‘biopsy’ for kids with brain tumors is simple, safe way to see if treatment is working 19
Product News 21
Jan 05, 2018: Advanced MRI Can Detect Placental Perfusion Abnormalities in Pregnancies Complicated by Fetal CHD 21
Aug 24, 2017: New published study shows incisionless surgery with MR-HIFU highly effective in destroying painful bone tumors 22
Other Significant Developments 23
Sep 26, 2018: Six pediatric device innovators awarded total of $150,000 at Children’s National 6th Annual Pediatric Device Symposium 23
Jan 26, 2017: Cerner, Children’s National to Expand IT Platform with Revenue Cycle Suite 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Children’s National Health System, Medical Equipment, Key Facts 2
Children’s National Health System, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Children’s National Health System, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Children’s National Health System, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Children’s National Health System, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Children’s National Health System, Deals By Market, 2012 to YTD 2018 8
Children’s National Health System, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regeneron Genetics Center Enters into Research Agreement with Children's National Health System 10
OZ Systems Enters Into Co-Development Agreement With Children's National Health System 11
Children's National Health System Forms Joint Venture with Cerner 12
Summit Enters Into Co-Development Agreement With Children's National Medical Center 13
Children’s National Health System, Key Competitors 14
Children’s National Health System, Key Employees 15

List of Figures
Children’s National Health System, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Children’s National Health System, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Children’s National Health System, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Children’s National Health System, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Children’s National Health System, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Children’s National Health System, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Children’s National Health System, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Children’s National Health System, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Children’s National Health System:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zimnat Group:企業の戦略・SWOT・財務情報
    Zimnat Group - Strategy, SWOT and Corporate Finance Report Summary Zimnat Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Softchoice Corporation:企業の戦略・SWOT・財務情報
    Softchoice Corporation - Strategy, SWOT and Corporate Finance Report Summary Softchoice Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Owlstone Medical Ltd:企業の製品パイプライン分析2018
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, am …
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AngloGold Ashanti Limited:戦略・SWOT・企業財務分析
    AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mott MacDonald Group Ltd:企業の戦略的SWOT分析
    Mott MacDonald Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Canon Medical Systems Corp:医療機器:M&Aディール及び事業提携情報
    Summary Canon Medical Systems Corp (Canon Medical Systems), formerly known as Toshiba Medical Systems Corp, a subsidiary of Canon Inc, is a provider of medical diagnostic systems and comprehensive medical solutions. The company’s product portfolio include computed tomography systems, magnetic resona …
  • AIA Group Limited:企業の戦略・SWOT・財務情報
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Amunix Operating Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Amunix Operating Inc (Amunix) is a biotechnology company that discovers and develops long-acting protein-based therapeutics. The company develops protein and peptide therapeutics. It uses its proprietary technology platform XTEN, a proprietary recombinant polypeptide that consists of natural …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Henkel AG & Co KGaA (HEN3):企業の財務・戦略的SWOT分析
    Henkel AG & Co KGaA (HEN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Empresa Nacional del Petroleo:電力:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Pharmerica Corp:企業の戦略的SWOT分析
    Pharmerica Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆